Internal Medicine, Endocrinology, Diabetes, & Metabolism · Brooklyn, NY
NPI
1013953975
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
1655 E 13th St
Brooklyn, NY, 11229
Phone (718) 339-3100
Groups this clinician bills Medicare through
Medicare paid, 2024
$325K
4,003 services
Medicare patients, 2024
556
Average age 77
Drug cost, 2024
$8.6M
25,281 prescriptions
Company payments, 2025
$4,951
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matin Sharafatkhah was code 99214 (office e&m - established), 1,313 times for 445 patients. In total Matin Sharafatkhah billed 4,003 services in 28 codes, and Medicare paid $325K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-10-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,313 | 445 | $117.27 | $154K |
| 96372 Injection Administration | Office | 523 | 172 | $13.29 | $6,951 |
| 99213 Office E&M - Established | Office | 447 | 232 | $81.16 | $36K |
| 76536 Ultrasound - Nonspecific | Office | 289 | 282 | $101.96 | $29K |
| 95249 Test - Miscellaneous | Office | 243 | 51 | $64.31 | $16K |
| 36415 Venipuncture Blood Collection | Office | 180 | 140 | $6.68 | $1,202 |
| 76700 Ultrasound - Abdomen and Pelvis | Office | 164 | 162 | $110.80 | $18K |
| 77080 Standard X-ray | Office | 129 | 128 | $47.66 | $6,148 |
| 77081 Standard X-ray | Office | 128 | 128 | $38.61 | $4,942 |
| 95921 Electrical Nerve Conductivity | Office | 102 | 100 | $82.42 | $8,406 |
| 95923 Electrical Nerve Conductivity | Office | 102 | 100 | $116.97 | $12K |
| 93922 Duplex Scan - Extremity Arteries | Office | 90 | 89 | $81.33 | $7,319 |
| 95251 Test - Miscellaneous | Office | 83 | 51 | $32.19 | $2,672 |
| 99204 Office E&M - New | Office | 74 | 74 | $146.86 | $11K |
| 99212 Office E&M - Established | Office | 74 | 44 | $48.89 | $3,618 |
By year: 2022 $299K for 3,482 services; 2023 $318K for 3,817 services; 2024 $325K for 4,003 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 180 | 140 | $6.68 | $1,202 |
Medicare prescription drug claims, 2024
In 2024, the drug Matin Sharafatkhah prescribed most often to Medicare patients was Metformin Hcl, with 1,842 prescriptions and refills. In total Matin Sharafatkhah wrote 25,281 Medicare prescriptions that cost $8.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metformin Hcl Generic | 1,842 | 2,087 | 259 | $12K |
| Synthroid Levothyroxine Sodium | 1,704 | 1,909 | 201 | $82K |
| Vascepa Icosapent Ethyl | 1,527 | 1,630 | 226 | $543K |
| Mounjaro Tirzepatide | 1,331 | 1,379 | 196 | $1.4M |
| Atorvastatin Calcium Generic | 1,010 | 1,194 | 171 | $3,872 |
| Jardiance Empagliflozin | 906 | 976 | 132 | $570K |
| Rosuvastatin Calcium Generic | 868 | 980 | 137 | $7,328 |
| Alcohol Prep Pads Alcohol Antiseptic Pads | 852 | 1,143 | 157 | $16K |
| Tradjenta Linagliptin | 700 | 776 | 103 | $387K |
| Ezetimibe Generic | 670 | 756 | 92 | $7,331 |
| Farxiga Dapagliflozin Propanediol | 648 | 710 | 96 | $395K |
| Glimepiride Generic | 530 | 566 | 72 | $3,649 |
| Janumet Sitagliptin Phos/Metformin Hcl | 459 | 474 | 62 | $260K |
| Icosapent Ethyl Generic | 452 | 476 | 103 | $60K |
| Pioglitazone Hcl Generic | 445 | 538 | 61 | $2,074 |
Brand drugs: 13,231 claims; generic drugs: 9,357 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matin Sharafatkhah $4,951 ($4,951 in general payments such as food, travel and fees) from 26 companies. The largest payer was Abbvie Inc. with $942.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 31 | $942 |
| Amgen Inc. AMGN | 21 | $570 |
| Lilly USA, LLC LLY | 16 | $570 |
| Xeris Pharmaceuticals, Inc. | 14 | $392 |
| Corcept Therapeutics CORT | 8 | $359 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 16 | $352 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $264 |
| Novo Nordisk Inc NVO | 10 | $243 |
| Medtronic, Inc. MDT | 7 | $150 |
| Ascendis Pharma Endocrinology Inc ASND | 2 | $149 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.